scholarly journals Framing global discourses on non-communicable diseases: a scoping review

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Melisa Mei Jin Tan ◽  
Emeline Han ◽  
Pami Shrestha ◽  
Shishi Wu ◽  
Farah Shiraz ◽  
...  

Abstract Background The choices that policymakers make are shaped by how their problems are framed. At last, non-communicable diseases (NCDs) have risen high on the global policy agenda, but there are many disputed issues. First, what are they? Their name refers not to what they are but what they are not. Second, where do their boundaries lie? What diseases are included? Third, should we view their causes as mainly biomedical, behavioural, or social, or a combination? Our failure to resolve these issues has been invoked as a reason for our limited progress in developing and implementing effective remedies. In this scoping review, we ask “What is known from the existing literature about how NCDs are framed in the global policy discourses?” We answer it by reviewing the frames employed in policy and academic discourses. Methods We searched nine electronic databases for articles published since inception to 31 May 2019. We also reviewed websites of eight international organisations to identify global NCDs policies. We extracted data and synthesised findings to identify key thematic frames. Results We included 36 articles and nine policy documents on global NCDs policies. We identified five discursive domains that have been used and where there are differing perspectives. These are: “Expanding the NCDs frame to include mental health and air pollution”; “NCDs and their determinants”; “A rights-based approach to NCDs”; “Approaches to achieving policy coherence in NCDs globally”; and “NCDs as part of Sustainable Socio-economic Development”. We further identified 12 frames within the five discursive domains. Conclusions This scoping review identifies issues that remain unresolved and points to a need for alignment of perspectives among global health policy actors, as well as synergies with those working on mental health, maternal health, and child health. The current COVID-19 pandemic warrants greater consideration of its impact on global NCDs policies. Future global strategies for NCDs need to consider explicitly how NCDs are framed in a changing global health discourse and ensure adequate alignment with implementation and global health issues. There is a need for global strategies to recognise the pertinent role of actors in shaping policy discourses.

2016 ◽  
Vol 2 (3_suppl) ◽  
pp. 44s-44s
Author(s):  
Shannon L. Silkensen ◽  
John S. Flanigan

Abstract 78 In many low and middle-income countries (LMICs) there is a marked need to build or enhance research infrastructure to support basic, translational, clinical, and population science on non-communicable diseases, mental health and injuries (NCDs). To support this growing need, the NCI's Center for Global Health recently invited investigators throughout the world to apply for Planning Grants for Regional Infrastructure Centers (RCREs) for the coordination of research on NCDs in LMICs. The purpose of the funding opportunity (FOA) is to facilitate the planning and designing of RCRE that will build on collaborative partnerships among investigators from institutions in high-income countries (HICs)/ Upper Middle Income Countries (UMIC) and LMICs. The presentation will provide details of the opportunity for funding from the NCI, how partnerships can be created, the requirements for the application to the program and its multiple funding timelines, and early information about the program's global reach. The NCI Center for Global Health encourages the CUGH community to examine and become involved in this this opportunity as primary or partner applicants. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST: No COIs from either author.


Author(s):  
Marco Zenone ◽  
Benjamin Hawkins

Suzuki et al. have identified commonalities in the policy positions adopted at a global forum by commercial sector actors and high-income countries, on the one hand, and non-governmental organizations and low- and middle-income countries, on the other, in ways that may allow commercial sector actors to block or delay evidence-based policies through the creation of political controversy. The ability of industry actors to draw on the support of the most politically and economically powerful countries for their favoured policy agenda is an important contribution to understanding the dynamics of global health governance in the area of non-communicable diseases and beyond. Here we assess the relevance of this paper for the field of corporate actors’ research and the potential avenues this opens up for further study. More specifically we emphasize the need for comparative, cross disciplinary research to examine the power of heath-harming industries and the relevance of these findings for decolonizing global health.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Farah Naja ◽  
Hibeh Shatila ◽  
Maria El Koussa ◽  
Lokman Meho ◽  
Lilian Ghandour ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. e033320 ◽  
Author(s):  
Fantu Abebe Eyowas ◽  
Marguerite Schneider ◽  
Biksegn Asrat Yirdaw ◽  
Fentie Ambaw Getahun

IntroductionMultimorbidity is the coexistence of two or more chronic non-communicable diseases (NCDs) in a given individual. Multimorbidity is increasing in low- and middle-income countries (LMICs) and challenging health systems. Individuals with multimorbidity are facing the risk of premature mortality, lower quality of life and greater use of healthcare services. However, despite the huge challenge multimorbidity brings in LMICs, gaps remain in mapping and synthesising the available knowledge on the issue. The focus of this scoping review will be to synthesise the extent, range and nature of studies on the epidemiology and models of multimorbidity care in LMICs.MethodsPubMed (MEDLINE) will be the main database to be searched. For articles that are not indexed in the PubMed, Scopus, PsycINFO and Cochrane databases will be searched. Grey literature databases will also be explored. There will be no restrictions on study setting or year of publication. Articles will be searched using key terms, including comorbidity, co-morbidity, multimorbidity, multiple chronic conditions and model of care. Relevant articles will be screened by two independent reviewers and data will be charted accordingly. The result of this scoping review will be presented using the Preferred Reporting Items for Systematic Review and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) checklist and reporting guideline.Ethics and disseminationThis scoping review does not require ethical approval. Findings will be published in peer-reviewed journal and presented at scientific conferences.


2019 ◽  
Vol 41 (10) ◽  
pp. 1479-1481
Author(s):  
Isabelle Malhamé ◽  
Louise Pilote ◽  
Rodney Destiné ◽  
Kerling Israel ◽  
Julia E. von Oettingen

Sign in / Sign up

Export Citation Format

Share Document